Zaia et al., Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy, Annals N.Y. Acad. Sci., vol. 660, pp. 95-106, Jan. 1992.* |
Geisler et al. Cell 71:613-621, Nov. 13, 1992.* |
Thanos et al. Cell 71:777-789, Nov. 27, 1992.* |
Laurence et al. J. Virology 65:213-219, Jan. 1991.* |
Bours et al Molecular and Cellular Biology 12:685-695, Feb. 1992.* |
Schmid et al. Nature 352:773-736, 1991.* |
Ghosh et al. Cell 62:1019-1029, 1980.* |
Kitajima et al. Science 258:1792-1795, Dec. 1992.* |
Stull. Pharm. Res. 12:465-483 (1995).* |
Rojanasakul, Adv. Drug Delivery 18 (1996) 115-131.* |
Gewirtz et al. PNAS 93:3161-3163 (1996).* |
Akhtar and Juliano, “Cellular Uptake and Intracellular Fate of Antisense Oligonucleotides,” Trends Cell Biol. 2:139-144 (1992). |
Alitalo et al., “Aberrant Expression of An Amplified c-myb oncogene in two cell lines from a colon carcinoma,” Proc. Natl. Acad. Sci. USA 81:4534-4538 (1984). |
Anfossi et al., “An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines,” Proc. Natl. Acad. Sci. USA 86:3379-3383 (1989). |
Austin et al., “Intimal Proliferation of Smooth Muscle Cells as an Explanation for Recurrent Coronary Artery Stenosis After Percutaneous Transluminal Coronary Angioplasty,” J. Am. Coll. Cardiol. 6:369-375 (1985). |
Ballantyne et al., “Nucleotide sequence of the cDNA for murine intracellular adhesion molecule-1 (ICAM-1),” Nucleic Acids Research 17:5853 (1989). |
Banskota et al., “Insulin, Insulin-Like Growth Factor I and Platelet-Derived Growth Factor Interact Additively in the Induction of the Protooncogene c-myc and Cellular Proliferation in Cultured Bovine Aortic Smooth Muscle Cells,” Molec. Endocrinol., 3:1183-1190 (1989). |
Barinaga, “Ribozymes: Killing the Messenger,” Science 262:1512-1514 (1993). |
Belknap et al., “Transcriptional Regulation in Vascular Cells; Genetically Modified Animals,” J. Cell. Biochem. S18A:277 (1994). |
Bennett et al., “Cationic Lipids Enhance Cellular Uptake and Activity of Phosphorothioate Antisense Oligonucleotides,” Mol. Pharmacology 41:1023-1033 (1992). |
Biotech Abstracts Act. #91-00050 EP 388758 (Sep. 26, 1990). |
Biro et al., “Inhibitory Effects of Antisense Oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration,” Proc. Natl. Acad. Sci. U S A, 90:654-658 (1993). |
Blam et al., “Addition of Growth Hormone Secretion Signal to Basic Fibroblast Growth Factors Results in Cell Transformation and Secretion of Aberrant Forms of the Protein,” Oncogene 3:129-136 (1988). |
Brown et al.,“Expression of the c-myb Proto-oncogene in Bovine Vascular Smooth Muscle Cells,” J. Biol. Chem. 267:4625-4630 (1992). |
Bywater et al., “Expression of Recombinant Platelet-Derived Growth Factor A-Chain and B-Chain Homodimers in Rat Cells and Human Fibroblastic Reveals Differences in Protein Processing and Autocrine Effects,” Mol. Cell. Biol. 8:2753-2762 (1988). |
Calabretta et al., “Normal and Leukemic Hematopoietic Cells Manifest Differential Sensitivity to Inhibitory Effects of c-myb Antisense Oligodeoxynucleotides: An in vitro study relevant to bone marrow purging,” Proc. Natl. Acad. Sci. USA, 88:2351-2355 (1991). |
Califf et al., “Restenosis: The Clinical Issues,” in Textbook of Interventional Cardiology, E.J. Topol, eds., W. B. Saunders, Philadelphia, pp. 363-394 (1990). |
Cameron and Jennings, “Specific Gene Suppression by Engineered Ribozymes in Monkey Cells.” Proc. Natl. Acad. Sci. USA 86:9139 (1989). |
Chen, “Multitarget-Ribozyme Directed to Cleave up to Nine Highly Conserved HIV-1 env RNA Regions Inhibits HIV-1 Replication-Potential Effectiveness Against Most Presently Sequenced HIV-1 Isolates,” Nucleic Acids Res. 20:4581-4589 (1992). |
Chowrira and Burke, “Extensive Phosphorothioate Substitution Yields Highly Active and Nuclease-Resistant Hairpin Ribozymes,” Nucleic Acids Res. 20:2835-2840 (1992). |
Chuat and Galibert, “Can Ribozymes be Used to Regulate Procaryote Gene Expression?” Biochem. and Biophys. Res. Commun. 162:1025 (1989). |
Cleary et al., “Cloning and Structural Analysis of cDNAs for bcl-2 and A Hybrid bcl-2/Immunoglobulin Transcript Resulting From the t(14;18) Translocation,” Cell 47:199-28 (1986). |
Clowes et al., “Kinetics of Cellular Proliferation After Arterial Injury,” Lab Invest. 49:327-333 (1983). |
Collins and Olive, “Reaction Conditions and Kinetics of Self-Cleavage of a Ribozyme Derived From Neurospora VS RNA,” Biochemistry 32:2795-2799 (1993). |
Cotten et al., “High Efficiency Receptor-Mediated Delivery of Small and Large (48 Kilobase Gene Constructs Using the Endosome-Disruption Activity of Defective or Chemically Inactivated Adenovirus Particles,” Proc. Natl. Acad. Sci. USA 89:6094-6098 (1992). |
Cotten et al., “Transferrin-Polycation-Mediated Introduction of DNA into Human Leukemic Cells: Stimulation by Agents that Affect the Survival of Transfected DNA or Modulate Transferrin Receptor Levels” (Abstract), Proc. Natl. Acad. Sci. USA 87:4033-4037 (1990). |
Cotten et al., “Chicken Adenovirus (CELO Virus) Particles Augment Receptor-Mediated DNA Delivery to Mammalian Cells and Yield Exceptional Levels of Stable Transformants,” J. Virol. 67:3777-3785 (1993). |
Cristiano et al., “Hepatic Gene Therapy: Adenovirus Enhancement of Receptor-Mediated Gene Delivery and Expression in Primary Hepatocytes,” Proc. Natl. Acad. Sci. USA 90:2122-2126 (1993). |
Curiel et al., “Adenovirus Enhancement of Transferrin-Polylysine-Mediated Gene Delivery,” Proc. Nat. Acad. Sci. USA, 88:8850-8854 (1991). |
Dropulic et al., “Functional Characterization of a U5 Ribozyme: Intracellular Suppression of Human Immunodeficiency Virus Type I Expression,” J Virol. 66:1432-1441 (1992). |
Eck et al., “Inhibition of Phorbol Ester-Induced Cellular Adhesion by Competitive Binding of NF-κB In Vivo,” Mol. Cell. Biol. 13:6530-6536 (1993). |
Edgington, “Ribozymes: Stop Making Sense,” Biotechnology 10:256-262 (1992). |
Elroy-Stein and Moss, “Cytoplasmic Expression Based on Constitutive Synthesis of Bacteriophage T7 RNA Polymerase in Mammalian Cells,” Proc. Natl. Acad. Sci. USA 87:6743-7 1990). |
Ferguson et al., “Compensation for Treating Wounds to Inhibit Scar Tissue—Contains Agent Esp. Antibody, Which Selectively Neutralises Fibrotic Growth Factors,” WPI Acc#92-3659974/44. |
Ferns et al., “Inhibition of Neointimal Smooth Muscle Accumulation After Angioplasty by an Antibody to PDGF,” Science 253:1129-1132 (1991). |
Gao and Huang, “Cytoplasmic Expression of a Reporter Gene by Co-Delivery of T7 RNA Polymerase and T7 Promoter Sequence with Cationic Liposomes,” Nucleic Acids Res. 21:2867-72 (1993). |
Garratt et al.,“Differential Histopathology of Primary Atherosclerotic and Restenotic Lesions in Coronary Arteries and Saphenous Vein Bypass Grafts: Analysis of Tissue Obtained From 73 Patients by Directional Atherectomy,” J. Am. Coll. Cardio. 17:442-428 (1991). |
Goldberg et al., “Vascular Smooth Muscle Cell Kinetics: A New Assay for Studying Patterns of Cellular Proliferation in vivo,” Science, 205:920-922 (1979). |
Griffin and Baylin, “Expression of the c-myb Oncogene in Human Small Cell Lung Carcinoma,” Cancer Res. 45:272-275 (1985). |
Grotendorst et al., “Attachment of Smooth Muscle Cells to Collagen and Their Migration Toward Platelet-Derived Growth Factor,” Proc. Natl. Acad. Sci. USA 78:3669-3672 (982). |
Guerrier-Takada et al., “The RNA Moiety of Ribonuclease P Is the Catalytic Subunit of the Enzyme,” Cell 35:849 (1983). |
Hajjar et al., “Tumor Necrosis Factor-Mediated Release of Platelet-Derived Growth Factor From Cultured Endothelial Cells,” J. Exp. Med. 166:235-245 (1987). |
Hampel et al., “‘Hairpin’ Catalytic RNA Model: Evidence for Helices and Sequence Requirement for Substrate RNA”, Nucleic Acids Research 18:299-304 (1990). |
Harris et al., “Receptor-Mediated Gene Transfer to Airway Epithelial Cells in Primary Culture,” Am. J. Respir. Cell Mol. Biol., 9:441-447 (1993). |
Haseloff and Gerlach, “Simple RNA Enzymes with New and Highly Specific Endoribonuclease Activities,” Nature 334:585-591 (1988). |
Herschlag, “Implications of Ribozyme Kinetics for Targeting the Cleavage of Specific RNA Molecules in vivo: More Isn't Always Better,” Proc. Natl. Acad. Sci. USA 88:6921-5 (1991). |
Hertel et al., “Numbering System for the Hammerhead,” Nucleic Acids Res. 20:3252 (1992). |
Higashiyama et al., “A Heparin-Binding Growth Factor Secreted by Macrophage-Like Cells That is Related to EFG,” Science 251:936-939 (1991). |
Jaeger et al., “Improved Predictions of Secondary Structures for RNA,” Proc. Natl. Acad. Sci. USA 86:7706-7710 (1989). |
Jeffries and Symons, “A Catalytic 13-mer Ribozyme,” Nucleic Acids Research 17:1371 (1989). |
Kashani-Sabet et al., “Reversal of the Malignant Phenotype by an Anti-ras Ribozyme,” Antisense Research & Development 1:3-15 (1992). |
Kaye et al., “Structure and Expression of the Human L-myc Gene Reveal a Complex Pattern Of Alternative mRNA Processing,” Mol. Cell. Biol. 8:186-195 (1988). |
Kindy and Sonenshein, “Regulation of Oncogene Expression in Cultured Aortic Smooth Muscle Cells,” J. Biol. Chem. 261:12865-12868 (1986). |
Kita et al., “Sequence and expression of rat ICAM-1,” Biochem. Biophys. Acta 1131:108-110 91992). |
Kitajima et al., “Ablation of Transplanted HTLV-I Tax-Transformed Tumors in Mice by Antisense Inhibition of NF-κB,” Science 258:1792-1795 (1992). |
Klagsbrun and Edelman, “Biological and Biochemical Properties of Fibroblast Growth Factors,” Arteriosclerosis 9:269-278 (1989). |
Koizumi et al., “Ribozymes Designed to Inhibit Transformation of NIH3T3 Cells by the Activated c-Ha-ras Gene,” Gene 117:179 (1992). |
Komuro et al., “Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells,” FEBS Letters 238:249-252 (1988). |
Kunapuli et al., “Molecular Cloning of Human Angiotensinogen cDNA and Evidence for the Presence of Its mRNA in Rat Heart—DNA Sequence,” Cir. Res. 60:786-790 (1987). |
Kunsch and Rosen, “NF-κB and Subunit-Specific Regulation of the Interleukin-8 Promoter,” Mol. Cell. Biol. 13:6137-6146 (1993). |
La Rosa et al., “Differential Regulation of the c-myc Oncogene Promoter by the NF-κB Rel Family of Transcription Factors,” Mol. Cell. Biol. 14:1039-1044 (1994). |
Lenardo and Baltimore, “NF-κB: A Pleiotropic Mediator of Inducible and Tissue Specific Gene Control,” Cell 58:227-229 (1989). |
Lieber et al., “Stable High-Level Gene Expression in Mammalian Cells by T7 Phage $NA Polymerase,” Methods Enzymol. 217:47-66 (1993). |
L'Huillier et al., “Cytoplasmic Delivery of Ribozymes Leads to Efficient Reduction in α-Lactalbumin mRNA Levels in C1271 Mouse,” Embo J. 11:4411-4418 (1992). |
Lindner and Reidy, “Proliferation of Smooth Muscle Cells After Vascular Injury Is Inhibited by an Antibody Against Basic Fibroblast Growth Factor,” Proc. Natl. Acad. Sci. USA 88:3739-3743 (1991). |
Lisziewicz et al., “Inhibition of Human Immunodeficiency Virus Type 1 Replication by Regulated Expression of a Polymeric Tat Activation Response RNA Decoy as a Strategy for Gene Therapy in AIDS,” Proc. Natl. Acad. Sci. U.S.A. 90:8000-8004 (1993). |
Liu et al., “Specific NF-κB Subunits Act in Concert with Tat To Stimulate Human Immunodeficiency Virus Type I Transcription,” J. Virology 66:3883-3887 (1992). |
Majello et al., “Human c-myb Protooncogene: Nucleotide Sequence of cDNA and Organization of the Genomic Locus,” Proc. Natl. Acad. Sci. USA, 83:9636-9640 (1986). |
Mamone et al., “Design of Hammerhead Ribozymes Targeted to Sequences in HIV, HSV and the RAT ANF Gene,” Abstract of Keystone, CO (May 27, 1992). |
McGrath et al., “Structure and Organization of the Human Ki-ras Protooncogene And a Related Processed Pseudogene,” 304:501-506 (1983). |
Melani et al., “Inhibition of Proliferation by c-myb Antisense Oligodeoxynucleotide in Colon Adenocarcinoma Cell Lines that Express c-myb,” Cancer Res. 51:2897-2901 (1991). |
Minvielle et al., “A Novel Calcitonin Carboxyl-Terminal Peptide Produced in Medullary Thyroid Carcinoma by Alternative RNA Processing of the Calcitonin-Calcitonin Gene-Related Peptide Gene,” J. Biol. Chem. 266:24627-24631 (1991). |
Nabel et al., “Site-Specific Gene Expression in Vivo by Direct Gene Transfer Into the Arterial Wall,” Science 249:1285-1288 (1990). |
Nabel et al., “Recombinant Platelet-Derived Growth Factor B Gene Expression in Porcine Arteries Induces Intimal Hyperplasia In Vivo,” J. Clin. Invest. 91:1822-1829 1993). |
Narayanan et al., “Evidence for Differential Functions of the p50 and p65 Subunits of NF-κB with a Cell Adhesion Model,” Mol. Cell. Biol. 13:3802-3810 (1993). |
O'Brien et al., “Vascular Cell Adhesion Molecule-1 is Expressed in Human Coronary Atherosclerotic Plaques,” J. Clin. Invest. 92:945-951 (1993). |
Ohno et al., “Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial Injury,” Science 265:781-784 (1994). |
Ohkawa et al., Nucleic Acids Symp. Ser. 27:15-6 (1992). |
Ojwang et al., “Inhibition of Human Immunodeficiency Virus Type 1 Expression by a Hairpin Ribozyme,” Proc. Natl. Acad. Sci. USA 89:10802-10806 (1992). |
Pavco et al., “Regulation of Self-Splicing Reactions by Antisense RNA,” Abstract of Keystone, CO (May 27, 1992). |
Perkins et al., “Distinct combinations of NF-κB subunits determine the specificity of transcriptional activation,” Proc. Natl. Acad. Sci. USA 89:1529-1533 (1992). |
Perreault et al., “Mixed Deoxyribo- and Ribo-Oligonucleotides with Catalytic Activity,” Nature 344:565-568 (1990). |
Perrotta and Been, “Cleavage of Oligoribonucleotides by a Ribozyme Derived from the Hepatitis δ Virus RNA Sequence,” Biochemistry 31:16 (1992). |
Pieken et al., “Kinetic Characterization of Ribonuclease-Resistant 2′-Modified Hammerhead Ribozymes,” Science 253:314-317 (1991). |
Popoma et al., “Clinical Trials of Restenosis After Coronary Angioplasty,” Circulation 84:1426-1436 (1991). |
Raines et al., “Interleukin-1 Mitogenic Activity for Fibroblasts and Smooth Muscle Cells Is Due to PDGF-AA,” Science 243:393-396 (1989). |
Raschella et al., “Inhibition of Proliferation by c-myb Antisense RNA and Oligodeoxynucleotides in Transformed Neuroectodermal Cell Lines,” Cancer Res. 52:4221-4226 (1992). |
Ratajczak et al., “In Vivo Treatment of Human Leukemia in a scid Mouse Model With c-myb Antisense Oligodeoxynucleotides,” Proc. Natl. Acad. Sci. USA 89:11823-11827 (1992). |
Ray and Prefontaine, “Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor,” Proc. Natl. Acad. Sci. USA 91:752-756 (1994). |
Read et al., “NF-κB and IκBα: An Inducible Regulatory System in Endothelial Activation,” J. Exp. Med. 179:503-512 (1994). |
Riessen et al., “Arterial Gene Transfer Using Pure DNa Applied Directly to a Hydrogel-Coated Angioplasty Balloon,”Human Gene Therapy 4:749-758 (1993). |
Ross et al., “A Platelet-Dependent Serum Factor That Stimulates the Proliferation of Arterial Smooth Muscle Cells In Vitro,” Proc. Natl. Acad. Sci. USA 71:1207-1210 (1974). |
Roessler et al., “Adenovirus-mediated Gene Transfer to Rabbit Synovium In Vivo,” J. Clin. Invest. 92;1085-1092 (1993). |
Rossi et al., J. Cell Biochem. Suppl 14A:D428 (1990). |
Rossi et al., “Ribozymes as Anti-HIV-1 Therapeutic Agents: Principles, Applications, and Problems,” Aids Research and Human Retroviruses 8:183 (1992). |
Ruben et al., “Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF, kappba B,” Science 251:5000 (1991). |
Ruben et al., “Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF, kappba B,” Science 254:5028 (1991). |
Ruben et al., Genes & Development 6:745-760 (1992). |
Sarver et al., “Ribozymes as Potential Anti-HIV-1 Therapeutic Agents,” Science 247:1222-1225 (1990). |
Sarver et al., “Catalytic RNAs (Ribozymes): A New Frontier in Biomedical Applications,” AIDS Res. Revs. 2:259 (1992). |
Saville and Collins, “A Site-Specific Self-Cleavage Reaction Performed by a Novel RNA In Neurospora Mitochondria,” Cell 61:685-696 (1990). |
Saville and Collins, “RNA-Mediated Ligation of Self-Cleavage Products of a Neurospora Mitochondrial Plasmid Transcript,” Proc. Natl. Acad. Sci. USA 88:8826-8830 (1991). |
Scanlon et al., “Ribozyme-Mediated Cleavage of c-fos mRNA Reduces Gene Expression of DNA Synthesis Enzymes and Metallothionein,” Proc. Natl. Acad. Sci. USA 88:10591-10595 (1991). |
Scaringe et al., “Chemical synthesis of biologically active oligoribonucleotides using β-cyanoethyl protected ribonucleoside phosphoramidites,” Nucl Acids Res. 18:5433-5441 (1990). |
Semba, “A v-erbB-Related Protooncogene, C-erB-2, Is Distinct From the c-erbB-1/Epidermal Growth Factor-Receptor Gene and Is Amplified in A Human Salivary Gland Adenocarcinoma,” Proc. Natl. Acad. Sci. USA 82:6497-6501 (1985). |
Seth et al., “Mechanism of Enhancement of DNA Expression Consequent to Cointernalization of a Replication-Deficient Adenovirus and Unmodified Plasmid dDNA,” J. Virol., 68:933-940 (1994). |
Sessa et al., “Molecular Cloning and Expression of a cDNA Encoding Endothelial Cell Nitric Oxide Synthase,” J. Biol. Chem. 267:15274-15276 (1992). |
Shi et al., “Downregulation of c-myc Expression by Antisense Oligonucleotides Inhibits Proliferation of Human Smooth Muscle Cell,” Circulation 88:1190-1195 (1993). |
Shu et al., “Differential Regulation of Vascular Cell Adhesion Molecule 1 Gene Expression by Specific NF-κB Subunits in Endothelial and Epithelial Cells,” Mol. Cell. Biol. 13:6283-6289 (1993). |
Simons et al., “Antisense c-myb Oligonucleotides Inhibit Intimal Arterial Smooth Muscle Cell Accumulation in vivo,” Nature 359:67-70 (1992). |
Simons et al., “Relation Between Activated Smooth Muscle Cells in Coronary-Artery Lesions and Restenosis After Atherectomy,” New Engl. J. Med. 328:608-613 (1993). |
Simmons et al., “ICAM, an adhesion ligand of LFA-1 is homologous to the neural cell adhesion molecule NCAM,” Nature 331:624-627 (1988). |
Sioud and Drulica, “Prevention of Human Immunodeficiency Virus Type 1 Integrase Expression in Escherichia coli by a Ribozyme,” Proc. Natl. Acad. Sci. USA 88:7303 (1991). |
Sjolund et al., “Arterial Smooth Muscle Cells Express Platelet-Derived Growth Factor (PDGF) A Chain mRNA, Secrete a PDGF-Like Mitogen, and Bind Exogenous PDGF in a Phenotype- and Growth State-Dependent Manner,” J. Cell. Biol. 106:403-413 (1988). |
Slamon et al., “Studies of the Human c-myb Gene and its Products in Human Acute Leukemias,” Science 233:3467-351 (1986). |
Slamon et al., “Expression of Cellular Oncogenes in Human Malignancies,” Science 224:256-262 (1984). |
Stull and Szoka, “Antigene, Ribozyme and Aptamer Nucleic Acid Drugs: Progress and Prospects,” Pharmaceutical Research 12:465-483 (1995). |
Taira et al., “Construction of a novel RNA-transcript-trimming plasmid which can be used both in vitro and in place of run-off and (G)-free transcriptions and in vivo as multi-sequences transcription vectors,” Nucleic Acids Research 19:5125-30 (1991). |
Ten Dijke et al., “Recombinant Transforming Growth Factor Type Beta-3 Biological Activities and Receptor-Binding Properties in Isolated Bone Cells,” Mol. Cell Biol. 10:4473-4479 (1990). |
Tessler et al, “Basic Fibroblast Growth Factor Accumulates in the Nuclei of Vairous BFGF-Producing Cell Types,” J. Cell. Physiol. 145:310-317 (1990). |
Thiele et al., “Regulation of c-myb Expression in Human Neuroblastoma Cells During Retinoic Acid-Induced Differentiation,” Mol. Cell. Biol. 8:1677-1683 (1988). |
Torelli et al., “Expression of c-myb Protooncogene and Other Cell Cycle-Related Genes in Normal and Neoplastic Human Colonic Mucosa,” Cancer Res. 47:5266-5269 (1987). |
Uhlenbeck, “A Small Catalytic Oligoribonucleotide,” Nature 327:596-600 (1987). |
Usman and Cedergren, “Exploiting the chemical synthesis of RNA,” Trends in Biochem. Sci. 17:334-339 (1992). |
Usman et al.,“Automated Chemical Synthesis of Long Oligoribonucleotides Using 2′-O-Silylated Ribonucleoside 3′-O-Phosphoramidtes on a Controlled-Pore Glass Support: Synthesis of a 43-Nucleoside Sequence Similar to the 3′-Half Molecule of an Escherichia coli Formylmethoionine tRNA,” J. Am. Chem. Soc. 109:7845-7854 (1987). |
van de Stolpe et al., “12-O-Tetradecanoylphorbol-13-acetate- and Tumor Necrosis Factor α-meidated Induction of Intercellular Adhesion Molecule-1 Is Inhibited by Dexamethasone,” J. Biol. Chem. 269:6185-6192 (1994). |
Ventura et al., “Activation of HIV-Specific Ribozyme Activity by Self-Cleavage,” Nucleic Acids Res. 21:3249-55 (1993). |
Weerasinghe et al., “Resistance to Human Immunodeficiency Virus Type 1 (HIV-1) Infection in Human CD4+ Lymphocyte-Derived Cell Lines Conferred by Using Retroviral Vectors Expressing and HIV-1 RNA-Specific Ribozyme,” Journal of Virology 65:5531-4 (1994). |
Weiser et al., “The Growth-Related Transcription Factor OCT-1 is Expressed as a Function of Vascular Smooth Muscle Cell Modulation,” J. Cell. Biochem. S18A:282 (1994). |
Westin et al., “Alternative Splicing of the Human c-myb Gene,” Oncogene 5:1117-1124 (1990). |
Willard et al., Circulation 86:I-473 (1992). |
Woolf et al., “Specificity of Antisense Oligonucleotides in vivo,” Proc. Natl. Acad. Sci. USA 89:7305-7309 (1992). |
Yu et al., “A Hairpin Ribozyme Inhibits Expression of Diverse Strains of Human Immunodeficiency Virus Type 1,” Proc. Natl. Acad. Sci. U S A 90:6340-6344 (1993). |
Zenke et al., “Receptor-mediated Endocytosis of Transferrin-Polycation Conjugates: An Efficient Way to Introduce DNA into Hematopoietic Cells” (Abstract), Proc. Natl. Acad. Sci. USA 87:3655-3659 (1990). |
Zhou et al., “Synthesis of Function mRNA in Mammalian ells by Bacteriophage T3 RNA Polymerse,” Mol. Cell. Biol. 10:4529-4537 (1990). |